European Parliament condemns Indian govt over Manipur violence during Modi’s France visit
The European Parliament condemned the Indian government for the violence in Manipur and called on it to protect minority rights, coinciding with Prime Minister Narendra ... Read More
FREYR Battery’s Giga Arctic project receives major boost with €100m EU grant
FREYR Battery, a global front-runner in next-generation battery cell production technology, has disclosed the receipt of a €100 million grant from the European Union (EU). ... Read More
Erdogan’s shocker: Sweden’s NATO dreams at mercy of Turkey’s EU ambitions
In an intriguing turn of events, Turkish President Recep Tayyip Erdogan declared that he would only support Sweden's bid for NATO membership if the European ... Read More
ALX Oncology gets EC’s orphan drug status for evorpacept in gastric cancer
ALX Oncology Holdings, an Australian immuno-oncology company focusing on CD47 checkpoint pathway blocking therapies, declared a significant milestone with its flagship drug candidate evorpacept securing ... Read More
Incyte bags Opzelura EC approval for treatment of non-segmental vitiligo
Incyte has secured marketing authorization for Opzelura (ruxolitinib) cream 15mg/g from the European Commission (EC) for non-segmental vitiligo with facial involvement in adults and adolescents, ... Read More
Bristol Myers Squibb gets Reblozyl EC approval for anemia associated with NTD beta thalassemia
Bristol Myers Squibb (BMY) has secured full marketing authorization for Reblozyl (luspatercept) from the European Commission (EC) for treating anemia associated with non-transfusion-dependent (NTD) beta ... Read More
Sanofi, Regeneron get Dupixent EC approval for eosinophilic esophagitis
French pharmaceutical company Sanofi and Regeneron, an American biotechnology company, have received the approval of the European Commission (EC) to market their Dupixent (dupilumab) injection ... Read More
Enhertu EU approval : Daiichi Sankyo, AstraZeneca get approval for HER2 low metastatic breast cancer
Daiichi Sankyo and AstraZeneca have received the approval of the European Union (EU) for their jointly developed Enhertu (trastuzumab deruxtecan) for the treatment of a ... Read More
Takeda gets QDENGA EC approval as dengue vaccine
Takeda has received the European Commission’s (EC) marketing authorization for the company’s dengue vaccine QDENGA (Dengue Tetravalent Vaccine ) (TAK-003). The QDENGA vaccine is indicated ... Read More
EU launches full-scale investigation into Microsoft, Activision deal
The European Commission has launched a full-scale phase 2 investigation to evaluate the previously announced acquisition of Activision Blizzard by Microsoft under the European Union ... Read More